Status:
RECRUITING
New-onset Chronic Pelvic Pain in Transgender People Using Testosterone Therapy: an Exploratory Qualitative Study.
Lead Sponsor:
University Hospital, Grenoble
Conditions:
Transgender Persons
Pelvic Pain
Eligibility:
All Genders
18+ years
Brief Summary
This descriptive qualitative study aim to describe the characteristics of pelvic pain in transgender (trans) individuals using testosterone therapy and the impact on their quality of life. This study ...
Detailed Description
This study ai to accurately describe the chronic pelvic plan (CPP) from which transmasculine people can suffer, as well as their impact on quality of life, and to understand what are the obstacles and...
Eligibility Criteria
Inclusion
- Being a trans masculine individual
- Taking a gender affirming hormonal therapy (GAHT)
- living close to Grenoble
- having pelvic pain that appeared or were modified after taking GAHT
Exclusion
- Subject under guardianship or subject deprived of liberty Refusal of voice recording
Key Trial Info
Start Date :
September 27 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT06487754
Start Date
September 27 2024
End Date
December 1 2025
Last Update
December 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UGA
Saint-Martin-d'Hères, France, 38100